옵션 체인은 다양한 행사가격과 만기일에 대한 Leet Technology의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Leet Technology에 대한 시장 심리를 평가합니다..

Leet Technology (OTC:LTES) 주식, 옵션 체인

Leet Technology Inc is a technology company developing and operating platforms focused on eSports platform in Malaysia. Its gaming platform allows tournament organizers, brands, players, and game developers to organize esports tournaments utilizing their platform tools.

LEET TECHNOLGY INC by Leet Technology Inc.

Leet Technology Inc

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Thursday.
Following the market opening Thursday, the Dow traded down 0.01% to 44,142.13 while the NASDAQ fell 0.27% to 19,979.88. The S&amp;P 500 also fell, dropping, 0.14% to 6,075.73.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a>
Leading and Lagging Sectors Real estate shares jumped by 0.7% on Thursday.
In trading on Thursday, energy shares fell by 0.7%.
Top Headline
U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Palisade Bio, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares shot up 73% to $2.42.</li>
<li>Shares of Trevi Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) got a boost, surging 62% to $4.0435 after the company announced positive outcomes for the treatment of patients from its chronic cough Phase 2b CORAL trial.</li>
<li>Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares were also up, gaining 52% to $0.1980.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sacks Parente Golf, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares dropped 80% to $0.28 after the company priced an upsized $8.4 million underwritten public offering of 7 million common units at $1.20 per unit.</li>
<li>Shares of Keros Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) were down 76% to $16.57 after the company announced it halted treatment in the 3.0 mg/kg and 4.5 mg/kg arms of its ongoing TROPOS trial due to safety concerns..</li>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) was down, falling 55% to $0.0740.</li>
</ul>
Commodities In commodity news, oil traded down 1.3% to $69.35 while gold traded down 1.7% at $2,709.80.
Silver traded down 3.7% to $31.710 on Thursday, while copper fell 0.8% to $4.2245.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.1%, Germany's DAX rose 0.2% and France's CAC 40 gained 0.2%. Spain's IBEX 35 Index slipped 0.1%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 gaining 1.21%, Hong Kong's Hang Seng Index gaining 1.20%, China's Shanghai Composite Index gaining 0.85% and India's BSE Sensex falling 0.29%.
Economics
<ul>
<li>U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000.</li>
<li>Core producer prices increased by 0.2% month-over-month in November compared to a 0.3% increase in the previous month and in-line with market expectations.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42460506/wall-streets-most-accurate-analysts-weigh-in-on-3-risk-off-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

GOEV

KROS

PALI

SPGC

TFFP

TRVI

Nasdaq Down 50 Points; US Initial Jobless Claims Rise

Guggenheim analyst Seamus Fernandez reiterates Apogee Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) from Buy to Buy.

Reiteration

Analyst Ratings

APGE

Guggenheim Reiterates Buy on Apogee Therapeuticsto Buy

Goldman Sachs analyst Duffy Fischer maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Neutral and lowers the price target from $56 to $48.

Price Target

Goldman Sachs Maintains Neutral on Dow, Lowers Price Target to $48

Goldman Sachs analyst Joe Ritchie maintains Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Buy and raises the price target from $202 to $223.

Goldman Sachs Maintains Buy on Dover, Raises Price Target to $223

Scotiabank analyst Andrew Weisel maintains Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) with a Sector Perform and raises the price target from $113 to $120.

Scotiabank Maintains Sector Perform on Duke Energy, Raises Price Target to $120

Guggenheim analyst John Heinbockel reiterates United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) from Neutral to Neutral.

UNFI

Guggenheim Reiterates Neutral on United Natural Foodsto Neutral

Scotiabank analyst Andrew Weisel maintains DTE Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTE#NYSE">DTE</a>) with a Sector Outperform and raises the price target from $137 to $147.

Scotiabank Maintains Sector Outperform on DTE Energy, Raises Price Target to $147

Goldman Sachs analyst Noah Poponak maintains Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) with a Buy and lowers the price target from $210 to $158.

Goldman Sachs Maintains Buy on Booz Allen Hamilton, Lowers Price Target to $158

Scotiabank analyst Andrew Weisel maintains Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) with a Sector Perform and raises the price target from $58 to $61.

Scotiabank Maintains Sector Perform on Dominion Energy, Raises Price Target to $61

Scotiabank analyst Andrew Weisel maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Sector Outperform and raises the price target from $75 to $77.

Scotiabank Maintains Sector Outperform on CMS Energy, Raises Price Target to $77

Goldman Sachs analyst Susan Maklari maintains AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) with a Buy and raises the price target from $52 to $59.

AZEK

Goldman Sachs Maintains Buy on AZEK Co, Raises Price Target to $59

Scotiabank analyst Andrew Weisel maintains Black Hills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>) with a Sector Perform and raises the price target from $63 to $67.

Scotiabank Maintains Sector Perform on Black Hills, Raises Price Target to $67

Goldman Sachs analyst James Schneider maintains American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) with a Buy and lowers the price target from $260 to $234.

Goldman Sachs Maintains Buy on American Tower, Lowers Price Target to $234

Guggenheim analyst Evan Wang reiterates Spruce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRB#NASDAQ">SPRB</a>) from Neutral to Neutral.

SPRB

Guggenheim Reiterates Neutral on Spruce Biosciencesto Neutral

Goldman Sachs analyst Jerry Revich maintains Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) with a Sell and raises the price target from $82 to $94.

ALSN

Goldman Sachs Maintains Sell on Allison Transmission, Raises Price Target to $94

IPOs

TTAN

ServiceTitan IPO Indicating $125/Share On 176,792 Shares; IPO Priced At $71/Share On 8.8M Shares

BuzzFeed Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) shares are trading lower by 11.9% to $3.93 during Thursday&#8217;s session, pulling back following earlier strength. The company announced the sale of First We Feast to an affiliate of Soros Fund Management for <a href="https://www.benzinga.com/pressreleases/24/12/b42461293/buzzfeed-inc-announces-sale-of-first-we-feast-to-an-affiliate-of-soros-fund-management-in-82-5-mil">$82.5 million in cash</a>.
What To Know: Per the company, the sale enables BuzzFeed to exceed its remaining debt with cash reserves after also partially prepaying convertible notes. BuzzFeed says this move marks a strategic pivot away from lower-margin content towards high-margin areas like programmatic advertising and affiliate commerce.
Read Also: <a href="https://www.benzinga.com/news/global/24/12/42460609/european-central-bank-lowers-interest-rates-fourth-cut-in-2024">European Central Bank Lowers Interest Rates, Fourth Cut In 2024</a>
CEO Jonah Peretti emphasized the company&#8217;s transformation, highlighting investments in AI-powered interactive experiences and scalable tech-enabled services as key growth drivers.
CFO Matt Omer noted significant debt reduction—over $150 million since December 2023—and projected stronger profitability, with adjusted EBITDA expected to grow by $12.7 million compared to 2023.
The performance of &#8220;First We Feast,&#8221; classified as a discontinued operation, will no longer factor into BuzzFeed&#8217;s financial results. For the fourth-quarter of 2024, the company expects revenues of $54–$58 million and adjusted EBITDA of $4–$9 million, excluding First We Feast's contributions.
Read Also: <a href="https://www.benzinga.com/news/treasuries/24/12/42460477/producer-inflation-rises-more-than-expected-to-3-in-november-cast-shadow-on-further-disinflation-progress">Producer Inflation Rises More Than Expected To 3% In November: All Eyes On The Fed&#8217;s Interest Rate Call</a>
<h2 class="wp-block-heading">How To Buy BZFD Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in BuzzFeed&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BZFD has a 52-week high of $5.68 and a 52-week low of $0.64.

BZFD

What's Going On With BuzzFeed (BZFD) Stock?

IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Thursday.</a>
IonQ has announced the display of its ion trap technology—the foundation of its quantum computers—at the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42459044/new-york-stock-exchange-showcases-ionq-technology-in-first-ever-recognition-of-a-quantum-company" rel="noreferrer noopener">New York Stock Exchange (NYSE).</a>
This display is a significant recognition of IonQ&#8217;s position in the quantum computing space and is the only quantum computing company featured at the NYSE, the world&#8217;s largest stock exchange.
Peter Chapman, President and CEO of IonQ, expressed pride in the achievement, stating that the display reflects both the potential of quantum computing and the company&#8217;s ability to bring quantum technology from the laboratory into real-world applications. As the first pure-play quantum computing company to go public in the U.S., IonQ is solidifying its role as a technological pioneer.
Also Read:<a target="_blank" href="https://www.benzinga.com/24/12/42462422/quantum-computing-meets-drones-zenatech-launches-sky-traffic-project-for-traffic-and-weather-optimization" rel="noreferrer noopener"> Quantum Computing Meets Drones: ZenaTech Launches Sky Traffic Project For Traffic, Weather Optimization</a>
The ion trap display will remain at the NYSE for six months, allowing thousands of entrepreneurs, investors, and global leaders who visit the exchange to view the cutting-edge technology. This showcases IonQ&#8217;s continuous growth and innovation.
IonQ has made significant strides in recent years, including securing a $54.5 million contract with the U.S. Air Force Research Lab and forging a <a target="_blank" href="https://investors.ionq.com/news/news-details/2024/IonQ-and-South-Koreas-Sungkyunkwan-University-Renew-International-Quantum-Alliance/default.aspx" rel="noreferrer noopener">partnership </a>with the South Korean government to advance the global quantum market.
The company had partnered with <a target="_blank" href="https://investors.ionq.com/news/news-details/2022/IonQ-Announces-Second-Quarter-2022-Financial-Results/default.aspx" rel="noreferrer noopener">Zapata </a>Computing and leveraged Nvidia&#8217;s CUDA-Q platform to test large language models on its quantum systems.
Investors can gain exposure to the stock via Main Thematic Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/TMAT#BATS">TMAT</a>). According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>,&nbsp;the stock has gained over 40% in the past month.
Price Action: IONQ shares are trading higher by 9.72% to $32.73 at last check Thursday.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42453807/spacex-hits-350-billion-valuation-in-insider-share-sale-ceo-elon-musk-says-no-investors-wanted-to-sell-shares" target="_blank" rel="noreferrer noopener">SpaceX Hits $350 Billion Valuation In Insider Share Sale: CEO Elon Musk Says &#8216;No Investors Wanted To Sell Shares&#8217;</a></li>
</ul>
Image via Shutterstock.

Movers

General

IONQ

TMAT

Quantum Computing Innovation: IonQ's Ion Trap On Display At NYSE

Guggenheim analyst Robert Drbul reiterates Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) from Neutral to Neutral.

Guggenheim Reiterates Neutral on Macy'sto Neutral

WIIM

Constellation Energy shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $237 to $269.

Comments

Leet Technology

Leet Technology (LTES) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌